Lumentum Holdings Inc.: Form 10-K for the period ended Jul 1, 2023
Filed with the SEC on Aug 23, 2023 and accepted by EDGAR at Aug 23, 2023, 20:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 12 months2022-07-03 to 2023-07-01 | $569.0m | us-gaap:GrossProfit |
| Research and development | 12 months2022-07-03 to 2023-07-01 | $307.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-07-03 to 2023-07-01 | $348.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-07-03 to 2023-07-01 | −$115.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-07-03 to 2023-07-01 | $35.5m | us-gaap:InterestExpense |
| Income tax | 12 months2022-07-03 to 2023-07-01 | $29.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-07-03 to 2023-07-01 | −$131.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-07-03 to 2023-07-01 | −$1.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-07-03 to 2023-07-01 | −$1.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-07-03 to 2023-07-01 | 68,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-07-03 to 2023-07-01 | $179.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-07-03 to 2023-07-01 | $128.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2022-07-03 to 2023-07-01 | $175.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-01 | $859.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $2.78bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $4.63bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $633.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $3.28bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-01 | $1.36bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-030374. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.